DCLK1 and pancreatic neoplasm: Knockdown of DCLK1 with siRNA or downregulation of DCLK1 with a kinase inhibitor (XMD8-92) results in decreased expression of angiogenic markers/VEGF receptors (VEGFR1 and VEGFR2) and EMT-related transcription factors ZEB1, ZEB2, Snail and Slug [19,52] in pancreatic tumor xenografts.